• PURPOSE
    • To study the use of a methylprednisolone taper (Medrol Dosepak; Pfizer, New York, NY) short-term oral corticosteroid treatment modality by sports medicine physicians; included is discussion on indications, perceived efficacy, and complications.
  • METHODS
    • A survey specific to Medrol Dosepak (MDP) use was mailed to all members of the Arthroscopy Association of North America (AANA) and the American Orthopedic Society for Sports Medicine (AOSSM). Surveys were collected and data were collated and analyzed.
  • RESULTS
    • Total response rate was 41% (1,290/3,167), US response rate 43% (1,247/2,906), and international response rate 16% (43/261). Prescribing of MDP for sports injuries was significantly associated with average patient age
  • CONCLUSIONS
    • The responding membership of AANA and AOSSM is evenly split regarding MDP use. Average patient age
  • LEVEL OF EVIDENCE
    • Level V, expert opinion.